A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
NCT03862950
Chromosome Disorders, Congenital Abnormalities
Edmonton, Alberta, Canada
View Trial DetailsNCT Number: NCT01953068
Up to 50% of patients undergoing surgical aortic valve operation suffer from some level of post-operative cognitive dysfunction (POCD). Frontal lobes of the brain, where executive functions are located, are highly susceptible to trauma caused by possible blood malperfusion to these areas of the brain during surgery. Conventional and established neuropsychological test methods are poor in distinguishing these kinds of trauma, as they are isolated, structured tests that do not require multitasking and processing of multiple stimuli at the same time.
The phase 1 goal of this study is to employ an experimental Executive reaction time (RT) test to see if this method could improve objective detection of subtle brain dysfunction assumed to underlie persistent cognitive, somatic, and affective complaints reported by patients who have undergone electic aortic valve replacement (AVR) surgery. Phase 2 of the study will concentrate on patients undergoing transcatheter aortic valve implantation (TAVI).
Looking for future studies?
Notify Me60 year–85 year
All sexes
Observational
Tampere University Hospital Heart Center, Tampere, Pirkanmaa, Finland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Time frame: 6 months
Tampere University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03862950
Chromosome Disorders, Congenital Abnormalities
Edmonton, Alberta, Canada
View Trial DetailsNCT05934422
Allergy, Atopic Dermatitis
Auckland, New Zealand
View Trial DetailsNCT03479476
Chromosome Disorders, Congenital Abnormalities
Sacramento, California, United States
View Trial DetailsNCT04937452
Aphasia, Aphasia, Primary Progressive
Rome, <None>, Italy
View Trial Details